![]() Kevin Stone and his team at The Stone Research Foundation for Sports Medicine and Arthritis were awarded $1,316,215 to develop an approach to treat and repair damaged cartilage using a patient’s own stem cells. It highlights our commitment to helping good science progress, hopefully from the bench to the bedside where it can help patients.ĭr. This research is based on an earlier project that CIRM funded. The goal is to show that, when placed in the knee joint, this can help regenerate and repair the damaged tissue. Those are then seeded onto a scaffold made from collagen fibers to create tissue that resembles the knee meniscus. The team will use stem cells to produce meniscal cells in the lab. The reductions in healthcare costs are also likely to be significant. There are significant socioeconomic benefits to preventing disabling osteoarthritis. These injuries accelerate the early development of osteoarthritis, for which there is no effective treatment other than total joint replacement, which is a major operation. Every year around 750,000 Americans experience a tear in their meniscus, the cartilage cushion that prevents the bones in the knee grinding against each other. Darryl D’Lima and his team at Scripps Health were awarded $1,620,645 to find a way to repair a torn meniscus. The program promotes the discovery of promising new stem cell-based and gene therapy technologies that could be translated to enable broad use and ultimately, improve patient care.ĭr. ![]() The projects were among 17 approved by CIRM as part of the DISC2 Quest Discovery Program. ![]() Today the governing Board of the California Institute for Regenerative Medicine (CIRM) approved two projects targeting repair of damaged cartilage. Oakland, CA – Every year millions of Americans suffer damage to their cartilage, either in their knee or other joints, that can eventually lead to osteoarthritis, pain and immobility. ![]()
0 Comments
Leave a Reply. |